18
Views
33
CrossRef citations to date
0
Altmetric
Original Article

Modifications of the Osmotic Pressure of Perilymph and Endolymph: An Hypothesis on the Pathogenesis of Menière's disease

Pages 360-377 | Published online: 08 Jul 2009
 

Abstract

The introduction of a saturated solution of NaCI into the middle ear of a cat or guinea pig provoked a biphasic vestibular spontaneous picture, which is composed of a 1st phase of “irritative” signs (nystagmus beating towards the injected side, etc.) and of a 2nd phase of “paralytic” signs (nystagmus beating towards the non-injected side, etc). Histologi-cal, electrophysiological, biochemical, and biophysical (osmotic pressure measurements) investigations have been carried out in many series of experiments performed by the author and his collaborators. It has been demonstrated that the changes of osmotic pressure between the peri-lymph and the endolymph are the essential pathogenetic factors of all clinical, histological, and electrophysiological manifestations occurring in the experiment. Close analogies are indicated between the effects of the experiment and the pathogenetic factors and evolution of Meniere's acute attacks: in fact, a Meniere's attack shows “irritative” signs followed by “paralytic” signs. Furthermore, in these experiments and in a Meniere's attack there are identical histological pictures of a “collapse” of the endolymphatic duct.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.